You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Touchlight receives funding to develeop DNA vaccine platform

Touchlight – a company which focuses on genetic medicine revolution – is furthering pre-clinical development of its proprietary doggybone DNA vaccine platform.